CIBC Asset Management Inc Increases Stock Position in Astera Labs, Inc. $ALAB

CIBC Asset Management Inc grew its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 41.0% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 6,838 shares of the company’s stock after purchasing an additional 1,988 shares during the quarter. CIBC Asset Management Inc’s holdings in Astera Labs were worth $1,138,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the business. Assetmark Inc. lifted its stake in Astera Labs by 374.1% in the 3rd quarter. Assetmark Inc. now owns 128 shares of the company’s stock valued at $25,000 after buying an additional 101 shares in the last quarter. Hilltop National Bank increased its position in Astera Labs by 100.0% during the fourth quarter. Hilltop National Bank now owns 200 shares of the company’s stock worth $33,000 after buying an additional 100 shares in the last quarter. Aventura Private Wealth LLC purchased a new position in Astera Labs during the fourth quarter worth $33,000. National Bank of Canada FI raised its holdings in shares of Astera Labs by 159.0% in the third quarter. National Bank of Canada FI now owns 202 shares of the company’s stock worth $39,000 after acquiring an additional 124 shares during the last quarter. Finally, Wexford Capital LP acquired a new position in shares of Astera Labs in the third quarter worth $39,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

ALAB has been the topic of a number of analyst reports. TD Cowen increased their price objective on Astera Labs from $140.00 to $225.00 and gave the company a “hold” rating in a research note on Wednesday, May 6th. Rothschild & Co Redburn assumed coverage on shares of Astera Labs in a research note on Friday, May 1st. They issued a “neutral” rating and a $153.00 target price for the company. Citigroup lowered shares of Astera Labs from a “buy” rating to a “market perform” rating in a report on Tuesday, May 26th. Royal Bank Of Canada lifted their price target on shares of Astera Labs from $250.00 to $270.00 and gave the stock an “outperform” rating in a report on Wednesday, May 6th. Finally, Weiss Ratings raised shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, May 21st. Twelve research analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $233.75.

Astera Labs Stock Up 9.2%

Shares of NASDAQ:ALAB opened at $346.33 on Tuesday. The company has a market cap of $59.36 billion, a P/E ratio of 234.01, a P/E/G ratio of 4.20 and a beta of 3.94. The business has a fifty day simple moving average of $217.60 and a 200-day simple moving average of $173.27. Astera Labs, Inc. has a 52 week low of $84.78 and a 52 week high of $372.37.

Astera Labs (NASDAQ:ALAB) last released its earnings results on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The firm had revenue of $308.36 million for the quarter, compared to the consensus estimate of $292.19 million. During the same period in the prior year, the business posted $0.33 earnings per share. The firm’s revenue for the quarter was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. Sell-side analysts expect that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Insider Activity

In other news, COO Sanjay Gajendra sold 400,000 shares of the stock in a transaction dated Thursday, May 21st. The shares were sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the transaction, the chief operating officer directly owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This represents a 7.32% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction that occurred on Wednesday, April 1st. The stock was sold at an average price of $107.61, for a total transaction of $19,692,630.00. Following the completion of the sale, the director directly owned 319,863 shares in the company, valued at $34,420,457.43. This represents a 36.39% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 2,321,256 shares of company stock valued at $480,893,146 in the last 90 days. 10.40% of the stock is currently owned by insiders.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.